Panacea Patient Recruitment
Open a previous report

Patient Recruitment · 2026

First Contact Speed in Clinical Trial Recruitment

A patient who enquires about a trial is, at that moment, as motivated as they're ever going to be. Every hour that passes before someone reaches them is an hour that motivation can fade — and it's a gap most studies aren't actually measuring.

Panacea Patient Recruitment · Patient recruitment specialists for clinical trials · Last updated: 29 August 2026

Patient Recruitment · 2026

First Contact Speed
in Trial Recruitment

The metric most studies don't track

First contact speed in clinical trial recruitment comes down to one number: how many minutes pass before someone responds — because that number predicts conversion more reliably than almost anything else in the pathway.

Key Takeaways

  • The odds of qualifying an enquiry fall 21-fold between a 5-minute and a 30-minute response window (MIT / InsideSales.com Lead Response Management Study).
  • Contact success rates drop more than tenfold within the first hour after an enquiry goes unanswered, with attempts after 20 hours offering little further value.
  • Introducing a standardised contact schedule cut the mean time to first patient contact from 8.8 days to 5.3 days in a real clinical trial recruitment pipeline (Burns et al., JAMIA Open, 2025).
  • The same standardisation shortened the full candidate-to-study-completion cycle by 19 days, from 92 to 73.
  • Roughly 80% of conversions take five or more follow-up attempts, yet 44% of people responsible for follow-up give up after just one (Marketing Donut / TeleNet and Ovation Sales Group research).
  • A study can have excellent sourcing and still underperform badly if enquiries sit for days before anyone follows up — from a topline report, that looks exactly like a sourcing failure.
  • Speed, traceability and continuity from enquiry to first contact are one connected story, not three separate line items — treating them separately is how the leak stays invisible.

What is first-contact speed, and why does it get overlooked?

First-contact speed is the time between a patient enquiring about a trial and someone genuinely attempting to reach them — a call placed, a message sent, an email that actually goes out. It's distinct from sourcing, which is about finding the right patients in the first place, and distinct from follow-up, which is what happens if that first attempt doesn't land.

Ask a study team how recruitment is going and the answer usually leans on sourcing: which channels are producing enquiries, how many are landing, whether the source mix looks healthy. Ask what happens in the hours after a patient enquires, and the answer is often far less precise, because sourcing is visible and easy to report on, while first-contact speed is harder to measure — which is exactly why it tends to go unmeasured rather than because it matters less.

Why does the gap between enquiry and contact matter so much?

A patient who enquires about a trial is, at that moment, as motivated as they're ever going to be. Every hour that passes before someone reaches them is an hour in which that motivation can fade, a competing option can appear, or life simply gets in the way. This is why speed, traceability and continuity from enquiry to first contact are best understood as one connected story: how the enquiry is transferred to whoever needs to act on it, how quickly that first contact actually happens, and what happens if that first attempt doesn't land.

It's tempting to treat referral capability as one big bucket — sourcing, contact, follow-up, all blurred into a general sense of whether recruitment is going well. In practice these are separable failure points, and a study can be strong in one and quietly weak in another, a distinction covered in more depth in why your clinical trial might be under-enrolling.

How does slow first contact actually cost a study patients?

A study can have excellent sourcing — the right channels, well-targeted, generating genuinely relevant enquiries — and still underperform badly if those enquiries sit for days before anyone follows up. From the patient's side, there's no difference between "we never found the right patients" and "we found them and lost them to a slow response." The outcome is identical; only the fix is different.

Slow first contact on its own is a fixable operational issue. Slow first contact combined with no defined follow-up protocol is something else — it's a leak with no way to see how much is being lost through it. If a study doesn't measure how long enquiries sit before contact, and has no defined follow-up cadence for attempts that don't land on the first try, an unknown number of relevant, motivated patients are being lost silently.

  • 5 MINUTES

    Baseline — highest odds of qualifying the enquiry

  • 10 MINUTES

    Qualification odds already down roughly 4×

  • 30 MINUTES

    Qualification odds down 21× versus 5 minutes

  • 1 HOUR

    Contact success down more than tenfold

  • 20 HOURS

    Further contact attempts add little value

Every step down this list is minutes, not days — the steepest odds drop happens well within the first hour.

What does the evidence say about response speed and conversion?

The clearest data on this comes from a large lead-response study conducted with MIT researcher James Oldroyd, analysing three years of data from six companies — more than fifteen thousand leads and over a hundred thousand call attempts. It found that the odds of qualifying a lead fell fourfold between 5 and 10 minutes of response time, and 21-fold by 30 minutes. Contact success dropped more than tenfold within the first hour, and the study noted that attempts made after roughly 20 hours added little further value.

Clinical-trial-specific evidence points the same way. A 2025 study published in JAMIA Open by Burns and colleagues found that introducing a standardised contact schedule — a baseline email followed by up to three calls until decline or scheduling — cut the mean time to first patient contact from 8.8 days to 5.3 days, and shortened the full candidate-to-study-completion cycle from 92 days to 73. The improvement came specifically from replacing an ad hoc, variable process with a defined cadence.

21×lower odds of qualifying an enquiry at 30 minutes vs 5 minutesMIT / InsideSales.com study
10×+drop in contact success within the first hour of no responseMIT / InsideSales.com study
8.8→5.3days to first contact after a standardised schedule was introducedBurns et al., JAMIA Open, 2025
19 daysshorter full candidate-to-completion cycle under the same protocolBurns et al., JAMIA Open, 2025
80%of conversions take five or more follow-up attemptsMarketing Donut research
44%of people responsible for follow-up give up after just one attemptTeleNet / Ovation Sales Group
Response window / findingWhat it showsSource
5 vs 30 minutes21-fold drop in qualification oddsMIT / InsideSales.com Lead Response Management Study
Within the first hourContact success down more than tenfoldMIT / InsideSales.com Lead Response Management Study
Standardised schedule (clinical trials)Mean time to first contact cut from 8.8 to 5.3 daysBurns et al., JAMIA Open, 2025
Follow-up cadence, general research80% of conversions need 5+ attempts; 44% quit after oneMarketing Donut / TeleNet-Ovation Sales Group

What happens when strong sourcing meets slow contact?

A recruitment shortfall that's actually rooted in slow or unmeasured first contact often doesn't look like a contact problem from a distance. It looks like a general enrolment shortfall, which gets attributed to sourcing because sourcing is the more visible, more frequently discussed part of the pathway. Teams respond by adding more channels and spending more on outreach, and the number doesn't move, because the problem was never how many patients were being found — it was how many of them were being reached in time.

This is exactly the kind of finding that requires looking at the relationship between two answers rather than either one in isolation: a strong source mix and a slow, unmeasured contact process aren't two separate observations, they're one finding. It's also why continuity matters once more than one team is involved — a coordinator handing an enquiry to a site for pre-screening needs the same speed standard to hold at that handoff as it did at the first one, or the gain from a fast first response gets undone one step later.

What does this mean for your recruitment pathway?

If enrolment is behind expectation and the source mix looks reasonable on paper, first-contact speed and follow-up discipline are worth examining before assuming the problem is upstream. Whether contact happens quickly at all depends partly on how the enquiry reaches the team in the first place — the same real-time visibility that prevents a referral from sitting unnoticed is what allows first-contact time to be tracked as a number rather than an impression, and it's also what makes it possible to see the gap covered in closing the loop on outcome data — a fast first contact that's never measured is a win nobody can point to.

What should you check about your first-contact process?

  • Do you know the actual median and worst-case time from enquiry to first contact attempt, or is "we're usually pretty quick" the honest answer?
  • Is there a defined follow-up cadence for enquiries that don't convert on the first attempt, or does a second try depend on someone remembering?
  • If more than one team touches an enquiry before it becomes a referral, does the patient's context and urgency travel with it, or does it start again at each handoff?
  • Would a slow or dropped enquiry currently show up as its own line item, or would it simply blend into a general "under-enrolling" number?

The gap between enquiry and contact is rarely the most discussed part of a recruitment pathway, but it's one of the more fixable, measurable parts of it — and fixing it tends to improve numbers that look, on the surface, like a sourcing problem.

Related reading

Find out how fast your enquiries actually get answered

Panacea's Clinical Trial Recruitment Diagnostic looks specifically at first-contact speed alongside referral transfer method and follow-up, because the three together tell a more accurate story than any one alone.

Take the Recruitment Diagnostic

Methodology & sourcing note

Statistics in this article are drawn from the MIT / InsideSales.com Lead Response Management Study (Professor James Oldroyd, three years of data across six companies, 15,000+ leads and 100,000+ call attempts), a 2025 clinical-trial-specific study by Burns and colleagues published in JAMIA Open on standardised contact scheduling, and general follow-up-attempt research attributed to TeleNet and Ovation Sales Group, Sirius Decisions and Marketing Donut, aggregated via a Geckoboard sourcing page — linked inline at each claim above. The lead-response and follow-up-attempt figures are general sales research, not clinical-trial-specific, and are presented as analogous evidence for the same underlying mechanism rather than as clinical trial statistics; the Burns et al. findings are the clinical-trial-specific anchor for this article.

Frequently asked questions

Panacea Patient Recruitment

Patient recruitment specialists for clinical trials · panaceapatientrecruitment.com/about-us

Last updated: 29 August 2026